Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,830 | -16,526 | -19,024 | -22,470 | -16,902 |
| Depreciation Amortization | 13,861 | 2,551 | 2,191 | 1,592 | 1,504 |
| Accounts receivable | -3,393 | 2,412 | -3,702 | -1,222 | 209 |
| Accounts payable and accrued liabilities | 107 | 1,802 | -1,815 | 540 | 932 |
| Other Working Capital | -7,849 | 7,427 | -4,759 | -1,338 | 1,869 |
| Other Operating Activity | 27,481 | 743 | 9,631 | 5,356 | 880 |
| Operating Cash Flow | $-22,623 | $-1,591 | $-17,478 | $-17,542 | $-11,508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,403 | -3,446 | -2,384 | -1,676 | -1,529 |
| Net Acquisitions | -113,190 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -132,644 | -59,436 | -35,385 | -71,379 | 0 |
| Sale Of Investment | 74,852 | 36,557 | 51,770 | 29,966 | 0 |
| Purchase Sale Intangibles | N/A | -1,240 | N/A | -2,000 | 0 |
| Other Investing Activity | 0 | -1,240 | 0 | -2,021 | 196 |
| Investing Cash Flow | $-178,385 | $-27,565 | $14,001 | $-45,110 | $-1,333 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 195,213 | 0 | 1,875 | 5,000 | 3,125 |
| Debt Repayment | N/A | 0 | -12,065 | -12,867 | 0 |
| Common Stock Issued | 5,113 | 5,806 | 58,711 | 78,234 | 39 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 633 |
| Financing Cash Flow | $200,326 | $5,806 | $48,521 | $70,367 | $3,797 |
| Exchange Rate Effect | -866 | -38 | 52 | 115 | 165 |
| Beginning Cash Position | 35,261 | 58,649 | 13,553 | 5,723 | 14,602 |
| End Cash Position | 33,713 | 35,261 | 58,649 | 13,553 | 5,723 |
| Net Cash Flow | $-1,548 | $-23,388 | $45,096 | $7,830 | $-8,879 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,623 | -1,591 | -17,478 | -17,542 | -11,508 |
| Capital Expenditure | -7,403 | -3,446 | -2,384 | -1,676 | -1,539 |
| Free Cash Flow | -30,026 | -5,037 | -19,862 | -19,218 | -13,047 |